Cargando…
Dysregulated CD38 Expression on Peripheral Blood Immune Cell Subsets in SLE
Given its uniformly high expression on plasma cells, CD38 has been considered as a therapeutic target in patients with systemic lupus erythematosus (SLE). Herein, we investigate the distribution of CD38 expression by peripheral blood leukocyte lineages to evaluate the potential therapeutic effect of...
Autores principales: | Burns, Marie, Ostendorf, Lennard, Biesen, Robert, Grützkau, Andreas, Hiepe, Falk, Mei, Henrik E., Alexander, Tobias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957821/ https://www.ncbi.nlm.nih.gov/pubmed/33670902 http://dx.doi.org/10.3390/ijms22052424 |
Ejemplares similares
-
Increased levels of immature and activated low density granulocytes and altered degradation of neutrophil extracellular traps in granulomatosis with polyangiitis
por: Lipka, Spyridon, et al.
Publicado: (2023) -
Cell-Specific Type I IFN Signatures in Autoimmunity and Viral Infection: What Makes the Difference?
por: Kyogoku, Chieko, et al.
Publicado: (2013) -
SIGLEC1 is a biomarker of disease activity and indicates extraglandular manifestation in primary Sjögren's syndrome
por: Rose, Thomas, et al.
Publicado: (2016) -
Dysregulation of immunity in COVID-19 and SLE
por: Hejazian, Seyyed Sina, et al.
Publicado: (2022) -
BTLA Expression and Function Are Impaired on SLE B Cells
por: Wiedemann, Annika, et al.
Publicado: (2021)